← Open Payments lookup

CHRISTOPHER BOJRAB: Open Payments

NPI 1689659013 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$104,564 in 289 payments from 21 companies in 2025. Trend: 2023 $199,999 · 2024 $136,139 · 2025 $104,564

Speaker / faculty: $51,997Honoraria: $25,114Consulting: $13,916Food & beverage: $6,868Travel & lodging: $5,539Speaker / faculty: $1,050
CompanyPaymentsAmount
Axsome Therapeutics, Inc.53$27,176
ABBVIE INC.59$26,022
Vanda Pharmaceuticals Inc.52$18,218
Eli Lilly and Company6$12,058
Teva Pharmaceuticals USA, Inc.16$8,968
Otsuka America Pharmaceutical, Inc.22$5,790
E.R. Squibb & Sons, L.L.C.15$3,446
Noven Therapeutics, LLC2$1,050
Neurocrine BioSciences, Inc.21$451
JAZZ PHARMACEUTICALS INC.7$413

Products named: Auvelity, VRAYLAR, FANAPT, AUSTEDO XR, REXULTI, COBENFY, Xelstrym, HETLIOZ.

Industry payments across IN — which companies pay providers there.